Elicio Therapeutics, Inc. (ELTX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$39.57M | +23.8% |
| 2024 | -$51.90M | -47.5% |
| 2023 | -$35.20M | -24.8% |
| 2022 | -$28.21M | +48.3% |
| 2021 | -$54.57M | +31.9% |
| 2020 | -$80.11M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$39.57M | +23.8% |
| 2024 | -$51.90M | -47.5% |
| 2023 | -$35.20M | -24.8% |
| 2022 | -$28.21M | +48.3% |
| 2021 | -$54.57M | +31.9% |
| 2020 | -$80.11M | — |